Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunoglobulin Replacement Therapy Versus Antibiotic Prophylaxis as Treatment for Incomplete Primary Antibody Deficiency.
Smits BM, Kleine Budde I, de Vries E, Ten Berge IJM, Bredius RGM, van Deuren M, van Dissel JT, Ellerbroek PM, van der Flier M, van Hagen PM, Nieuwhof C, Rutgers B, Sanders LEAM, Simon A, Kuijpers TW, van Montfrans JM. Smits BM, et al. Among authors: kleine budde i. J Clin Immunol. 2021 Feb;41(2):382-392. doi: 10.1007/s10875-020-00841-3. Epub 2020 Nov 18. J Clin Immunol. 2021. PMID: 33206257 Free PMC article. Clinical Trial.
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.
Hofstra JJ, Kleine Budde I, van Twuyver E, Choi G, Levi M, Leebeek FW, de Monchy JG, Ypma PF, Keizer RJ, Huitema AD, Strengers PF. Hofstra JJ, et al. Among authors: kleine budde i. Clin Immunol. 2012 Mar;142(3):280-90. doi: 10.1016/j.clim.2011.11.005. Epub 2011 Nov 16. Clin Immunol. 2012. PMID: 22197071 Clinical Trial.
Allergenicity assessment of apple cultivars: hurdles in quantifying labile fruit allergens.
Zuidmeer L, van Leeuwen WA, Kleine Budde I, Breiteneder H, Ma Y, Mills C, Sancho AI, Meulenbroek EJ, van de Weg E, Gilissen L, Ferreira F, Hoffmann-Sommergruber K, van Ree R. Zuidmeer L, et al. Among authors: kleine budde i. Int Arch Allergy Immunol. 2006;141(3):230-40. doi: 10.1159/000095293. Epub 2006 Aug 22. Int Arch Allergy Immunol. 2006. PMID: 16926543
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, van den Berg B, Doets AY, Leonhard SE, Verboon C, Huizinga R, Drenthen J, Arends S, Budde IK, Kleyweg RP, Kuitwaard K, van der Meulen MFG, Samijn JPA, Vermeij FH, Kuks JBM, van Dijk GW, Wirtz PW, Eftimov F, van der Kooi AJ, Garssen MPJ, Gijsbers CJ, de Rijk MC, Visser LH, Blom RJ, Linssen WHJP, van der Kooi EL, Verschuuren JJGM, van Koningsveld R, Dieks RJG, Gilhuis HJ, Jellema K, van der Ree TC, Bienfait HME, Faber CG, Lovenich H, van Engelen BGM, Groen RJ, Merkies ISJ, van Oosten BW, van der Pol WL, van der Meulen WDM, Badrising UA, Stevens M, Breukelman AJ, Zwetsloot CP, van der Graaff MM, Wohlgemuth M, Hughes RAC, Cornblath DR, van Doorn PA; Dutch GBS Study Group. Walgaard C, et al. Lancet Neurol. 2021 Apr;20(4):275-283. doi: 10.1016/S1474-4422(20)30494-4. Epub 2021 Mar 17. Lancet Neurol. 2021. PMID: 33743237 Clinical Trial.
Effect and safety of 4% albumin in the treatment of cardiac surgery patients: study protocol for the randomized, double-blind, clinical ALBICS (ALBumin In Cardiac Surgery) trial.
Vlasov H, Juvonen T, Hiippala S, Suojaranta R, Peltonen M, Schramko A, Arvonen K, Salminen US, Kleine Budde I, Eränen T, Mazanikov M, Meinberg M, Vähäsilta T, Wilkman E, Pettilä V, Pesonen E. Vlasov H, et al. Among authors: kleine budde i. Trials. 2020 Feb 28;21(1):235. doi: 10.1186/s13063-020-4160-3. Trials. 2020. PMID: 32111230 Free PMC article.
Inadvertent BSA-induced elution of IgE in the BSA-RAST.
Kleine Budde I, de Heer PG, Stapel SO, van der Zee JS, Aalberse RC. Kleine Budde I, et al. Allergy. 2001 Nov;56(11):1055-60. doi: 10.1034/j.1398-9995.2001.00290.x. Allergy. 2001. PMID: 11703218
An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies.
Mauser-Bunschoten EP, Kleine Budde I, Lopaciuk S, Koopman MM, Van Der Meer FJ, Novàkovà IR, Ypma P, Van Der Linden PW, Windyga J, Strengers PF. Mauser-Bunschoten EP, et al. Among authors: kleine budde i. Haemophilia. 2011 May;17(3):439-45. doi: 10.1111/j.1365-2516.2010.02453.x. Epub 2011 Mar 1. Haemophilia. 2011. PMID: 21362109 Clinical Trial.
11 results